Endocrine

, Volume 43, Issue 3, pp 472–484

Methylglyoxal, obesity, and diabetes

Review

DOI: 10.1007/s12020-012-9795-8

Cite this article as:
Matafome, P., Sena, C. & Seiça, R. Endocrine (2013) 43: 472. doi:10.1007/s12020-012-9795-8

Abstract

Methylglyoxal (MG) is a highly reactive compound derived mainly from glucose and fructose metabolism. This metabolite has been implicated in diabetic complications as it is a strong AGE precursor. Furthermore, recent studies suggested a role for MG in insulin resistance and beta-cell dysfunction. Although several drugs have been developed in the recent years to scavenge MG and inhibit AGE formation, we are still far from having an effective strategy to prevent MG-induced mechanisms. This review summarizes the mechanisms of MG formation, detoxification, and action. Furthermore, we review the current knowledge about its implication on the pathophysiology and complications of obesity and diabetes.

Keywords

DiabetesHyperglycemiaMethylglyoxal

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Paulo Matafome
    • 1
    • 2
    • 3
  • Cristina Sena
    • 1
  • Raquel Seiça
    • 1
  1. 1.Laboratory of PhysiologyInstitute of Biomedical Research on Light and Image (IBILI), Faculty of Medicine, University of CoimbraCoimbraPortugal
  2. 2.Center of OphthalmologyInstitute of Biomedical Research on Light and Image (IBILI), Faculty of Medicine, University of CoimbraCoimbraPortugal
  3. 3.Faculty of MedicinePole III of University of CoimbraCoimbraPortugal